María Nieves Aranda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
María Nieves Aranda has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alba López‐Palacios
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM) Universitat de València Valencia Spain
2 shared publications - Andy Hernández-Montoto
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM) Universitat de València Valencia Spain
2 shared publications - Elena Aznar
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, 46022 Valencia, Spain
2 shared publications - Isabel Caballos
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM) Universitat de València Valencia Spain
2 shared publications - Ramón Martínez-Máñez
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Spain
2 shared publications Beatriz Sánchez‐Sendra
I 2SysBio Universidad de Valencia‐CSIC. Calle del Catedrático Agustín Escardino 9 Paterna 46980 Spain
1 shared publication
Latest Publications
- Open Access
- 21 April 2026
- Published by Wiley in Microbiologyopen
- Vol. 15 (2) , e70287
A Fluorogenic Biosensor for Direct Detection of Vibrio vulnificus , a Climate Change Biomarker
Vibrio vulnificus , a marine pathogen and climate change biomarker, poses serious risks to human and animal health through seafood consumption and seawater exposure. Rapid detection methods are urgently needed for both vibriosis diagnosis and surveillance in warming coastal waters. We report a fluorogenic biosensor based on nanoporous anodic alumina loaded with rhodamine B and capped with an oligonucleotide probe targeting a unique sequence of the vvhA cytolysin gene, specific to V. vulnificus . In the presence of the target DNA, the probe is displaced, pores open, and the fluorophore is released, generating a measurable signal. The biosensor exhibited high sensitivity and selectivity across diverse matrices, including fish mucus and serum, human serum, sterilized brackish water, and—critically—unprocessed natural lake and seawater samples, without DNA extraction or amplification. Detection limits ranged between 10² and 5 × 10² CFU mL⁻¹, comparable in sensitivity to state‐of‐the‐art qPCR assays. The biosensor outperformed conventional approaches in speed, simplicity, and cost‐effectiveness, while maintaining accuracy. These findings underscore the potential of this platform for integrated One Health applications, bridging environmental monitoring with rapid diagnosis of vibriosis in humans and animals. Preliminary results from this study were previously made available as a preprint in SSRN (DOI: https://ssrn.com/abstract=5032822 ).
- 21 April 2026
- Published by Wiley in Microbiologyopen
- Vol. 15 (2) , e70287
Open AccessA Fluorogenic Biosensor for Direct Detection of Vibrio vulnificus , a Climate Change Biomarker
Vibrio vulnificus , a marine pathogen and climate change biomarker, poses serious risks to human and animal health through seafood consumption and seawater exposure. Rapid detection methods are urgently needed for both vibriosis diagnosis and surveillance in warming coastal waters. We report a fluorogenic biosensor based on nanoporous anodic alumina loaded with rhodamine B and capped with an oligonucleotide probe targeting a unique sequence of the vvhA cytolysin gene, specific to V. vulnificus . In the presence of the target DNA, the probe is displaced, pores open, and the fluorophore is released, generating a measurable signal. The biosensor exhibited high sensitivity and selectivity across diverse matrices, including fish mucus and serum, human serum, sterilized brackish water, and—critically—unprocessed natural lake and seawater samples, without DNA extraction or amplification. Detection limits ranged between 10² and 5 × 10² CFU mL⁻¹, comparable in sensitivity to state‐of‐the‐art qPCR assays. The biosensor outperformed conventional approaches in speed, simplicity, and cost‐effectiveness, while maintaining accuracy. These findings underscore the potential of this platform for integrated One Health applications, bridging environmental monitoring with rapid diagnosis of vibriosis in humans and animals. Preliminary results from this study were previously made available as a preprint in SSRN (DOI: https://ssrn.com/abstract=5032822 ).
- Open Access
- 20 March 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (11)
Aptamer‐Capped Nanoporous Anodic Alumina for SARS‐CoV‐2 Spike Protein Detection
The COVID‐19 pandemic, which began in 2019, has highlighted the importance of testing and tracking infected individuals as a means of mitigating the spread of the virus. In this context, the development of sensitive and rapid methods for the detection of SARS‐CoV‐2, the virus responsible for COVID‐19, is crucial. Herein, a biosensor based on oligonucleotide‐gated nanomaterials for the specific detection of SARS‐CoV‐2 spike protein is presented. The sensing system consists of a nanoporous anodic alumina disk loaded with the fluorescent indicator rhodamine B and capped with a DNA aptamer that selectively binds the SARS‐CoV‐2 spike protein. The system is initially evaluated using pseudotype virus systems based on vesicular stomatitis virus carrying different SARS‐CoV‐2 S‐proteins on their surface. When the pseudotype virus is present, the cap of the solid is selectively removed, triggering the release of the dye from the pore voids to the medium. The nanodevice demonstrated its ability to detect pseudotype virus concentrations as low as 7.5·103 PFU mL. In addition, the nanodevice is tested on nasopharyngeal samples from individuals suspected of having COVID‐19.
- 20 March 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (11)
Open AccessAptamer‐Capped Nanoporous Anodic Alumina for SARS‐CoV‐2 Spike Protein Detection
The COVID‐19 pandemic, which began in 2019, has highlighted the importance of testing and tracking infected individuals as a means of mitigating the spread of the virus. In this context, the development of sensitive and rapid methods for the detection of SARS‐CoV‐2, the virus responsible for COVID‐19, is crucial. Herein, a biosensor based on oligonucleotide‐gated nanomaterials for the specific detection of SARS‐CoV‐2 spike protein is presented. The sensing system consists of a nanoporous anodic alumina disk loaded with the fluorescent indicator rhodamine B and capped with a DNA aptamer that selectively binds the SARS‐CoV‐2 spike protein. The system is initially evaluated using pseudotype virus systems based on vesicular stomatitis virus carrying different SARS‐CoV‐2 S‐proteins on their surface. When the pseudotype virus is present, the cap of the solid is selectively removed, triggering the release of the dye from the pore voids to the medium. The nanodevice demonstrated its ability to detect pseudotype virus concentrations as low as 7.5·103 PFU mL. In addition, the nanodevice is tested on nasopharyngeal samples from individuals suspected of having COVID‐19.